Clinical Trials for Relapsing Remitting Multiple Sclerosis

Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis

NCT ID: NCT05949580

This clinical trial is studying how well a digital care management platform can help people with Relapsing Remitting Multiple Sclerosis (RRMS) manage their condition. The goal is to see if using th...

Cladribine Tablets as an Exit Therapy Strategy

NCT ID: NCT06887426

This clinical trial is studying the use of Cladribine Tablets (CladT) as a potential last treatment option for older adults with Multiple Sclerosis (MS), specifically those with Relapsing Remitting...

Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis

NCT ID: NCT05706220

Administration of Fingolimod in Greek Patients With Multiple Sclerosis.

NCT ID: NCT06949956

This clinical trial is looking at the effectiveness of a medication called fingolimod in people with relapsing-remitting multiple sclerosis (RRMS). The study aims to see how well fingolimod works b...

Functional Outcomes From Diets in Multiple Sclerosis

NCT ID: NCT05327322

This clinical trial is looking at how two different diet plans might help people with multiple sclerosis (MS) feel better and improve their daily lives. Specifically, the study will test a diet tha...

Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms

NCT ID: NCT00919217

This clinical trial is looking at how different factors, like stress, hormonal changes, illnesses, and missed medications, might influence the symptoms of relapsing-remitting multiple sclerosis (RR...

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

NCT ID: NCT06796504

This clinical trial is testing a new device called the SetPoint System to see if it can help repair nerve damage in adults with a type of multiple sclerosis known as relapsing-remitting multiple sc...

Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

NCT ID: NCT04047628

The BEAT-MS trial is studying two different treatment options for people with severe relapsing multiple sclerosis (MS) who haven't responded well to other therapies. The two treatments being compar...

SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis

NCT ID: NCT03783416

The SIZOMUS trial is studying the safety and effectiveness of a medication called ixazomib (also known as NINLARO) for people with different types of multiple sclerosis (MS), including relapsing-re...

Rituximab and Ocrelizumab in Serum With Multiple Sclerosis

NCT ID: NCT06663111

This clinical trial, called ROS-MS, is looking at how two medications, rituximab and ocrelizumab, can be used to create personalized treatments for people with relapsing-remitting multiple sclerosi...

Productive Value of Sonographic Measurement of Optic Nerve in Transitional Multiple

NCT ID: NCT06435962

This clinical trial is looking at how measuring the diameter of the optic nerve using ultrasound can help doctors understand early signs of nerve damage and disability in people with relapsing remi...

Comparative Study of High-Efficacy Disease Modifying Treatment of Relapsing Multiple Sclerosis

NCT ID: NCT06159712

This clinical trial is looking at how well certain treatments work for people with active relapsing multiple sclerosis (MS). The researchers want to compare the effects of four specific medications...

Implementation of a Novel Functional Eye-Tracking Biomarker for Multiple Sclerosis

NCT ID: NCT05277740

This clinical trial is exploring a new, non-invasive eye-tracking software designed to help us understand how certain diseases, like Clinically Isolated Syndrome (CIS) and Relapsing Remitting Multi...

Investigation of Subclinical Markers of Multiple Sclerosis

NCT ID: NCT04604041

This clinical trial is looking into various markers that could help us understand multiple sclerosis (MS), particularly in patients with relapsing-remitting MS, which is a type of MS characterized ...